Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001447028-25-000120

Options or other derivatives

  • Director acquired 157,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sawhney Roger · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-04 Grant or award : show line 1 in the form Stock Option (Right to Buy) +157,600 157,600 D
Loading xslF345X05/wk-form4_1754510902.xml…